Mucosal disease activity | UC | CD | Non-IBD | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Active | Inactive | Active | Inactive | Active | Control | ||||||
n | 14 | 10 | 4 | 5 | 6 | 6 | |||||
Sex (M/F) | 8/6 | 7/3 | 3/1 | 4/1 | 1/4 | 4/2 | |||||
Age (y) | |||||||||||
Range | 24–59 | 33–65 | 19–44 | 19–52 | 44–64 | 32–72 | |||||
Mean | 38.2 | 38.7 | 28.2 | 30.4 | 52.6 | 53.3 | |||||
Disease duration (y) | |||||||||||
Range | 1–19 | 3–18 | 2–8 | 2–20 | |||||||
Mean | 8.3 | 10.2 | 5.0 | 10.4 | |||||||
Treatment | |||||||||||
Cyclosporin | 2 | 0 | 0 | 0 | |||||||
Steroid | 4 | 4 | 2 | 2 | |||||||
Sulphasalazine/5-ASA only | 4/1 | 5/0 | 0/1 | 0/2 | |||||||
No treatment | 3 | 1 | 1 | 1 |
UC, ulcerative colitis; CD, Crohn's disease; IBD, inflammatory bowel disease.